Professional Documents
Culture Documents
Original Studies: Originalni Naučni Radovi
Original Studies: Originalni Naučni Radovi
11
Summary Sažetak
Introduction. From the clinical and epidemiological point of view Uvod. Sa kliničkog i epidemiološkog aspekta veoma je značajno
it is very important to define easily measurable and simple anthro- definisanje lako merljivih i jednostavnih antropometrijskih poka-
pometric parameters of mass and distribution of adipose tissue that zatelja mase i distribucije masnog tkiva koji će istovremeno biti i
will also be good predictors of future complications of obesity. The dobri prediktori budućih komplikacija gojaznosti. Cilj našeg rada
aim of our study was to correlate anthropometric indicators of mass bila je korelacija antropometrijskih pokazatelja veličine i distribu-
and distribution of adipose tissue with the risk of developing cardi- cije masne mase sa rizikom od razvoja kardiovaskularnih bolesti i
ovascular diseases and diabetes. Material and Methods. The dijabetesa u narednih deset godina. Materijal i metode. Ispitana
study group consisted of 155 women aged 45.4±13.04y. The ant- je grupa od 155 žena prosečne starosti 45,4±13,04 godine, kod ko-
hropometric measurements were performed in order to assess adi- jih su izvršena antropometrijska merenja da bi se procenila masa
pose tissue mass and its specific distribution. The 10-year risk of masnog tkiva i njegova specifična distrbucija. Desetogodišnji ri-
developing cardiovascular diseases was assessed by using two sco- zik od razvoja kardiovaskularnih bolesti je izračunat primenom
re-systems: Framingham and Prospective Cardiovascular Munster dva skoring sistema: Framingham i Prospective Cardiovascular
Study, while the 10-year risk of development of diabetes was asse- Munster Study, dok je desetogodišnji rizik od razvoja dijabetesa
ssed by QDScore system. Results. According to our results, the izračunat primenom QDScore sistema. Rezultati. Prema rezulta-
waist-to-stature ratio was the best predictor of cardiovascular and tima našeg istraživanja, odnos obima struka i telesne visine bio je
diabetes risk (r=0.617-0.780; AUC=0.872). The estimated cut-off najbolji pokazatelj rizika (r=0,617-0,780; AUC=0,872). Procenje-
value for the waist-to-stature ratio in cardiovascular and diabetes na granična vrednost ovog parametra u diskriminaciji rizika izno-
risk prediction was 0.486. Apart from the waist-to-stature ratio, the sila je 0,486. Pored odnosa obima struka i telesne visine, značajnu
body mass index, body fat mass, waist circumference and indica- povezanost sa rizikom imali su i indeks telesne mase, obim stru-
tors of upper extremity adiposity also correlated strongly with the ka, masna masa i pokazatelji masne mase gornjeg ekstremiteta.
assessed risk. The anthropometric indicators of lower body adipo- Antropometrijski pokazatelji masnotkivnih depoa donjeg ekstre-
sity had no significant diagnostic values. Conclusion. The waist- miteta nisu imali značajnu dijagnostičku vrednost. Zaključak.
to-stature ratio is the best anthropometric indicator of cardiovascu- Odnos obima struka i visine je najbolji antropometrijski pokaza-
lar and diabetes risk. telj rizika za razvoj kardiovaskularnih bolesti i dijabetesa.
Key words: Antropometrija; Telesna visina; Obim struka; Masno Ključne reči: Anthropometry; Body Height; Waist Circumferen-
tkivo; Intraabdominalno masno tkivo; Faktori rizika; Kardiovasku- ce; Adipose Tissue; Intra-Abdominal Fat; Risk Factors; Cardio-
larne bolesti; Dijabetes melitus; Gojaznost; Žensko; Odrasli; Sred- vascular Diseases; Diabetes Mellitus; Obesity; Female; Adult;
nje godine Middle Aged
and subscapular skin-folds (T/SS). The surface of fatty study, which includes age, sex, diabetes mellitus or
mass of upper arm (F) was calculated according to the fasting glycemia ≥ 6.67 mmol/l, smoking habit, posi-
formula: F (mm2) = UAC2/4p - M, where M is the up- tive family anamnesis on cardiovascular diseases and
per arm muscle area (M(mm2) = (UAC - p x T)2/4p) diabetes, systolic blood pressure, body mass, body
[8]. height and antihypertensive therapy [10]. The risk for
Blood pressure was measured by using Riva development of diabetes mellitus type 2 in the next
Roccy sphyngomanometer and the values were ex- 10 years was calculated by using QDScore calculator
pressed in millimeters of mercury (mmHg). For the based on the age, sex, ethnic background, body mass
values of total serum cholesterol and triglycerides, index, diabetes mellitus, positive family anamnesis of
standard enzyme procedure was used, high density diabetes, former myocardial infarction, cerebrovas-
lipoprotein high density lipoprotein (HDL)-choles- cular insult or transitory ischemic attacks, smoking
terol was determined by precipitation with sodium habit, antihypertensive therapy and corticosteroid
phosphowolframate and low density lipoprotein therapy [11].
(LDL)-cholesterol was determined according to the The software package SPSS 11.5 for Windows was
formula of Friedewald et all. Fasting glycemia was used for the statistical analysis. The average, minimum
measured by Dialab glucose GOD-PAP method. and maximum values, as well as percents were used of
The risk for development of cardiovascular dis- the descriptive statistics. The relationship between
ease was calculated by using two scoring systems: scores and anthropometric parameters was tested by
Framingham and Prospective Cardiovascular Mun- using Spearman’s coefficient of correlation. The area
ster Study (PROCAM). The risk of ischemic heart under the receiver operating characteristic (ROC)
disease (Framingham risk score) was calculated as curve was analyzed to estimate the discriminative val-
recommended by the American Heart Association ues of anthropometric measurements in the prediction
(AHA) and American College of Cardiology (ACC) of cardiovascular and diabetes risk.
based on the data on age, sex, total and HDL-choles-
terol, systolic and diastolic blood pressure, presence Results
of diabetes and smoking habit [9]. The risk of coro-
nary heart disease was calculated by using PROCAM Table 1 presents the average values of measured
calculator, based on the results of the PROCAM anthropometric indicators. The nutritional level of the
Table 2. Descriptive statistics for blood pressure, metabolic parameters and cardiovascular and diabetes risk scores
Tabela 2. Deskriptivna statistika vrednosti krvnog pritiska, metaboličkih parametara, kardiovaskularnih skorova i
skora za razvoj tipa 2 dijabetesa
X±SD Min-Max
Systolic blood pressure (mmHg)/Sistolni krvni pritisak (mmHg) 112.88±14.60 90.00-170
Diastolic blood pressure (mmHg)/Dijastolni krvni pritisak (mmHg) 72.64±8.47 50-100
Glycemia (mmol/l)/Glikemija (mmol/l) 4.69±0.48 3.40-7.20
Triglycerides (mmol/l)/Trigliceridi (mmol/l) 1.30±1.10 0.46-12.50
Total cholesterol (mmol/l)/Ukupni holesterol (mmol/l) 5.79±1.20 2.76-8.93
HDL-cholesterol (mmol/l) 1.48±0.31 0.75-2.4
LDL-cholesterol (mmol/l) 3.79±1.08 1.79-6.92
examinees ranged from malnutrition to the 2nd de- with transitory ischemic attacks; positive family an-
gree of obesity, the average value of BMI being amnesis of diabetes and of cardiovascular diseases
24.96±3.98 kg/m2. The fat mass also varied widely, was found in 26.4% and 14.8% of the subjects, re-
the average value being 31.70±8.75%. spectively (9% of examinees used antihypertensive
Table 2 shows the average, minimum and maxi- therapy and nobody used corticosteroid therapy).
mum values of blood pressure parameters, lipid pro- The majority of the examinees had normal weight
file and glycemia. According to the anamnestic data (62.58%), while a little more than third of examinees
analyzed in the evaluation of risk of cardiovascular had excessive body mass (28.39% were overweight
diseases and diabetes, there were 18.4% smokers and and 9.03% were obese). The abdominal obesity was
0.65% diabetics; 1.29% had myocardial infarction, recorded in 41.29% of examinees (21.94% had ex-
65% had cerebrovascular insult and there was noboby tremely increased waist circumference); the possibili-
Table 3. Structure of the studied group according to the nutritional level, abdominal obesity and cardiovascular
and diabetes risk
Tabela 3. Struktura ispitivane grupe u odnosu na stepen uhranjenosti, prisustvo abdominalne gojaznosti i rizik od
razvoja kardiovaskularnih bolesti i dijabetesa
N (%)
Nutritional status (BMI)/Stepen uhranjenosti
<18.50 kg/m2 –
18.50-24.99 kg/m2 97 (62.58)
25.00-29.99 kg/m2 44 (28.39)
>30 kg/m2 14 (9.03)
Waist circumference/Obim struka
<80 cm 91 (58.71)
≥80 cm 64 (41.29)
≥88 cm 34 (21.94)
10-year risk of acute coronary events (Framingham risk score)
Rizik od razvoja koronarne bolesti srca u narednih 10 godina
<10% 138 (89)
10-20% 17 (10.97)
>20% –
10-year risk of acute coronary events (PROCAM risk score)
Rizik od razvoja koronarne bolesti srca u narednih 10 godina
<10% 153 (98.7)
10-20% 1 (0.65)
>20% 1 (0.65)
10-year risk of developing type 2 diabetes (QDScore)/Rizik od razvoja dijabetesa u narednih 10 godina
<10% 137 (88.4)
10-20% 15 (9.7)
>20% 3 (1.94)
Med Pregl 2013; LXVI (1-2): 11-18. Novi Sad: januar-februar. 15
Table 5. Results of discriminative value analysis of anthropometric parameters in cardiovascular and diabetes
risk assessment
Tabela 5. Rezultati analize diskriminativne vrednosti pojedinih antropometrijskih parametara u proceni rizika
od kardiovaskularnih bolesti i dijabetesa
Anthropometric parameters/Antropometrijski parametri AUC SE 95% confidence interval/interval pouzdanosti
Lower bound Upper bound
Donja granica Gornja granica
BMI .838** .042 .756 .919
Fat mass/Masna masa .831** .039 .755 .907
Upper arm circumference/Obim nadlaktice .802** .045 .714 .891
Forearm circumference/Obim podlaktice .790** .046 .700 .880
Chest circumference/Obim grudnog koša .797** .044 .711 .883
Waist circumference/Obim struka .847** .038 .772 .922
Hip circumference/Obim kukova .713** .052 .612 .814
Thigh circumference/Obim natkolenice .560 .056 .450 .670
Calf circumference/Obim potkolenice .584 .060 .467 .702
WHR .834** .037 .761 .908
WSR .872** .033 .807 .936
WTR .807** .044 .720 .894
Subscapular skin-fold/Podlopatični nabor .677* .056 .568 .787
Triceps skin-fold/Nabor nad tricepsom .750** .048 .656 .843
T/SS .465 .061 .346 .584
Anterior forearm skin-fold/Prednji nabor podlaktice .673* .053 .570 .776
Lateral forearm skin-fold/Spoljašnji nabor podlaktice .642* .060 .524 .759
Abdominal skin-fold/Nabor trbuha .745** .047 .653 .837
Thigh skin-fold/Nabor natkolenice .518 .060 .401 .635
Calf skin-fold/Nabor potkolenice .539 .062 .417 .660
Upper arm adipose tissue surface
.780** .046 .690 .870
Površina masnog tkiva nadlaktice
*Statistical significance of the result (level of significance p<0.05)
** Statistical significance of the result (level of significance p<0.01)
cumference has been selected as the most convenient have found that in women BMI correlates highly
and simplest parameter with its well defined and with protective HDL-cholesterol, and that BMI,
widely accepted sex specific referent values [16-19]. waist circumference, WHR and WSR represent
According to our results, almost half of the exami- significant predictors of risk for developing diabe-
nees had the increased values of waist circumference tes mellitus [23]. Our results suggest a significant
(41.29%), and the estimated cardiovascular and correlation of cardiovascular risk and diabetes risk
diabetes risk higher than 10% was recorded in a with almost every examined anthropometric pa-
bit less than a third of examinees, which corre- rameter. In addition to the WSR index, the waist
sponds to a higher referent value of waist circum- circumference, total fat mass and BMI have
ference (≥88cm). Aschwell et all.[20], however, re- proved to be the second best. A similar study of
gard the waist circumference and body height ra- adult population performed in Turkey yielded the
tio as the most precise one because it takes into identical results - WSR was the best risk predictor,
account one more body dimension, because two followed by BMI and waist circumference [24].
persons with different height and the same waist Subcutaneous adipose tissue is considered to
circumference will have different cardio-metabo- have an important role in the defense from insulin
lic risk. The significance of body height in deter- resistance because it accepts the excess of free fat-
mination of cardio-metabolic risk has been con- ty acids and prevents ectopic accumulation of fat
firmed by the results of many studies [21,22]. In [25,26]. It makes 85% of total fat mass [19], and in
our investigation, this indicator was singled out as women it is predominantly found in the glute-
the most significant predictor of cardiovascular ofemoral region. Therefore, a larger fat mass does
and diabetes risk (r=0.617-780, AUC=0.872). not have to be directly associated with the risk be-
A lot of studies have underlined the signifi- cause it can be the consequence of fat accumula-
cance of BMI and waist circumference. Ko et all tion in the subcutaneous adipose depot. It has been
Med Pregl 2013; LXVI (1-2): 11-18. Novi Sad: januar-februar. 17
shown that a larger peripheral fat mass is connect- mass indicators such as subscapular skin-fold, tri-
ed with lower metabolic risk in women with the ceps skin-fold and WHR index, in the prediction
same level of central obesity [27], but still it is not of metabolic profile especially in the prediction of
completely clear if the metabolic risk depends on glucose intolerance and insulin resistance [31-34].
the place of accumulation of subcutaneous adipose Our results also indicate that the above mentioned
tissue. Several studies [28-30] have confirmed that parameters are better indicators of risk for devel-
the size of fat tissue depots of lower extremity cor- oping diabetes than cardiovascular diseases, and
relates positively with a better metabolic profile, that the triceps skin-fold, upper arm skin-fold and
lower production of pro-inflammatory cytokines upper arm adipose tissue surface have the strong-
and bigger production of insulin sensitizing ad- est predictive value.
ponectine. According to our results, the indicators
of fat mass size in the lower body parts – skin- Conclusion
folds and the thigh, calf and hip circumferences
and waist-to-thigh ratio have a lower correlation The results of our investigation have clearly
with cardiovascular and diabetes risk than the in- singled out the waist-to-stature ratio as the best
dicators of central distribution; the analysis of the indicator of risk for development of cardiovascular
area under the curve has shown that these param- diseases and diabetes. The estimated cut-off value
eters do not have a significant diagnostic value. for this parameter was 0.486. In addition to this
The circumferences and skin-folds of upper ex- ratio, the body mass index, fat mass, waist circum-
tremity, as well as the upper arm adipose tissue ference and indicators of upper extremity fat mass
surface have shown a better correlation with the had a significant correlation with risk; while the
risk than the indicators of fat mass depots of lower anthropometric indicators of adipose tissue depots
extremity. Some studies have underlined the sig- of lower extremity had no significant diagnostic
nificance of abdominal and upper body part fat values.
References
1. Strategija za prevenciju i kontrolu hronicnih nezaraznih 12. Molarius A, Seidell JC. Selection of anthropometric in-
bolesti Republike Srbije. Available from: http://www. dicators for classification of abdominal fatness: a critical revi-
minzdravlja.info/downloads/Zakoni/Strategije. ew. Int J Obes Relat Metab Disord. 1998;22(8):719-27.
2. Ministarstvo zdravlja Republike Srbije. Kardiovasku- 13. Nicklas BJ, Penninx BWJH, Ryan AS, Berman DM,
larne bolesti u Srbiji [article on the internet] 2011 September Lynch NA, Dennis KE. Visceral adipose tissue cutoffs associ-
[cited 2011 Dec 2011]; Available from: http://www.batut.org. ated with metabolic risk factors for coronary heart disease in
rs/download/novosti. women. Diabetes Care 2003;26(5):1413-20.
3. Seidell JC, Verschuren WMM, van Leer EM, Kromhout 14. Stokić E, Tomić-Naglić D, Đerić M, Jorga J. Therape-
D. Overweight, underweight, and mortality: a prospective study utic options for treatment of cardiometabolic risk. Med Pregl
of 48287 men and women. Arch Intern Med 1996;156(9):958-63. 2009;62(Suppl):54-8.
4. Webber J. Changing epidemiology of obesity: implica- 15. Srdić B, Stokić E, Polzović A, Babović S. Abdominal-
tions for diabetes. In: Barnett AH, Kumar S, eds. Obesity and no masno tkiv: značaj i metode njegove detekcije. Med Pregl
diabetes. 2nd ed. Chiehester: John Wiley & Sons; 2009. 2005;58(5-6):258-64.
5. Ritchie SA, Connel JMC. The link between abdominalo- 16. Carey VJ, Walters EE, Colditz GA, Solomon CG, Wi-
besity, metabolic syndrome and cardiovascular disease. Nutr llet WC, Rosner BA, et al. Body fat distribution and risk of
Metab Cardiovasc Dis 2007;17(4):319-26. non-insulin-dependent diabetes mellitus in women. Am J Epi-
6. Klein S. The case of visceral fat: argument for the de- demiol 1997;145(7):614-9.
fense. J Clin Invest 2004;13(11):1530-2. 17. Canoy D. Coronary heart disease and body fat distri-
7. Pittas AG, Joseph NA, Greenber AS. Adipocytokines and bution. Curr Atheroscler Rep 2010;12(2):125-33.
insulin resistance. J Clin Endocrinol Metab 2004;89(2):447–52. 18. Stojanov O, Stokić E, Šveljo O. Značaj pojedinih an-
8. Frisanco AR. New norms of upper limb fat and muscle tropometrijskih parametara u determinisanju veličine i distri-
areas for assessment of nutritional status. Am J Clin Nutr bucije masne mase. Med Danas 2007;6(7-8):370-9.
1981;34:2540-5. 19. Klein S, Allison DB, Heymsfield SB, Kelley DE, Lei-
9. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, bel RL, Nonas C, et al. Waist circumference and cardiometa-
Silbershatz H, Kannel WB. Prediction of coronary heart dise- bolic risk: a consensus statement from Shaping America’s He-
ase using risk factor categories. Circulation 1998;97:1837-47. alth: Association for Weight Management and Obesity Pre-
10. Assman G, Cullen P, Schulte H. Simple scoring sche- vention. Am J Clin Nutr 2007;85:1197-202.
me for calculating the risk of acute coronary events based on 20. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is
the 10-year follow-up of the Prospective Cardiovascular Mun- a better screening tool that waist circumference and BMI for
ster (PROCAM) study. Circulation 2002;105:310-5. adult cardiometabolic risk factors: systematic review and me-
11. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, ta-analysis. Obes Rev 2012;13(3):275-86.
Brindle P. Predicting the risk of type 2 diabetes in England 21. Heymsfield SB, Heo M, Pietrobelli A. Are adult body cir-
and Wales: prospective derivation and validation of QDSCO- cumferences associated with height? Relevance to normative ran-
RE. Br Med J 2009;338:b880. ges and circumferential indexes. Am J Clin Nutr 2011;93:302-7.
18 Rastović M, et al. Adipose tissue and cardiovascular and diabetes risk
22. Ito S, Kato T, Yoshida T, Inagaki T, Sato K. Influence syndrome in middle-aged and older Chinese men and women.
of height and age on waist circumference in Japanese outpati- J Clin Endocrinol Metab 2010;95(9):4389-98.
ents with coronary risk factors. Nagoya Med J 2009;50:55-65. 30. Sreuth MS, Dekker JM, Visser M, Bouter LM, Steho-
23. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, uwer CD, Yudkin JS et al. Trunk fat and leg fat have indepen-
et al. Simple antropometric indexes and cardiovascular risk dent and opposite associations with fasting and postload gluco-
factors in Chinese. Int J Obes 1997;21:995-1001. se levels: the Hoorn study. Diabetes Care. 2004;27(2):372-7.
24. Can AS, Bersot TP, Gonen M. Anthropometric indices 31. Peiris AN, Hennes MI, Evans DJ, Wilson CR, Lee
and their relationship with cardiometabolic factors in a sam- MB, Kissebah AH. Relationship of anthropometric measure-
ple of Turkish adults. Public Health Nutr 2009;12(4):538-46. ments of body fat distribution to metabolic profile in preme-
25. Frayn KN. Adipose tissue as a buffer for daily lipid nopausal women. Acta Med Scand Suppl 1988;723:179-88.
flux. Diabetologia 2002;45(9):1201-10. 32. Mensink M, Feskens EJM, Kruijshoop M, de Bruin
26. Kissebah AH, Krakower GR. Regional adiposity and TWA, Saris WHM, Blaak EE. Subscapular skinfold thickness
morbidity. Physiol Rev 1994;74:761-811. distinguishes between transient and persistent impaired glucose
27. van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, tolerance: Study on Lifestyle-intervention and impaired glucose
Kohrt WM. Contributions of total and regional fat mass to tolerance Maastricht (SLIM). Diabetic Med 2003;20(7):552-7.
risk for cardiovascular disease in older women. Am J Physiol 33. Porter III JJ. The association of subscapular and tri-
Endocrinol Metab 2002;282:E1023-8. ceps skin fold thickness with the risk of diabetes mellitus in
28. Williams MJ, Hunter GR, Kekes-Szabo T, Snyder S, African, American, Hispanic and Caucasian adults. Public
Treuth MS. Regional fat distribution in women and risk of health theses. 2007 [cited on 2011 Dec 24]; 28. Available from:
cardiovascular disease. Am J Clin Nutr 1997;65(3):855-60. http://digitalarchive.gsu.edu/iph_theses/28
29. Wu H, Qi Q, Yu Z, Sun Q, Wang J, Franco OH, et al. 34. Kim J, Meade T, Haines A. Skinfold thickness, body
Independent and opposite associations of trunk and leg fat de- mass index, and fatal coronary heart disease: 30 year follow
pots with adipokines, inflammatory markers, and metabolic up of the Northwick Park heart study. J Epidemiol Communi-
ty Health 2006;60:275-9.
Rad je primljen 31. V 2012.
Recenziran 13. VI 2012.
Prihvaćen za štampu 8. X 2012.
BIBLID.0025-8105:(2013):LXVI:1-2:11-18.